Back
ESC2025 Premium Access

A combination of bedside lung ultrasound and left ventricular outflow tract velocity time integral reclassifies early SCAI Shock staging and mortality risk in patients with STEMI

Session: New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease
Topic: Noninvasive Diagnostic Methods
Speaker: Doctor G. Telo (Porto Alegre, BR)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Guilherme Telo

Hospital de Clínicas de Porto Alegre, Porto Alegre (Brazil)
0 follower

9 more presentations in this session

Discussant - Biomarkers and assessing outcomes in coronary artery disease

Access
Like
Thumbnail

Association between cortisol, glucose and hospital mortality in acute coronary syndromes: a causal inference analysis.

Speaker: Doctor S. Swieszkowski (Buenos Aires, AR)

Access
Abstract
Slides
Video
Like
Thumbnail

Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality

Speaker: Doctor S. Fathieh (Buckinghamshire, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Comparative predictive value of troponin I and troponin T for in-hospital ischemic and bleeding events in acute coronary syndrome

Speaker: Doctor J. Costabel (Buenos Aires, AR)

Access
Abstract
Like
Thumbnail

Growth differentiation factor 15 and all-cause and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX and EXCEED-J Studies

Speaker: Doctor H. Wada (Kyoto, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease

Speakers: Doctor G. Telo, Doctor S. Swieszkowski, Doctor S. Fathieh, Doctor J. Costabel, Doctor H. Wada
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources